A qualified computer engineering graduate, Akshay Kedari holds a commensurate passion for both writing and programming. Presently, Akshay develops content for healthcareopportunity.org and similar other portals. Apart from penning down pieces related to digitized healthcare, pharmaceuticals, and more, Akshay spends his free time enjoying bike rides and good food. He can be contacted at- [email protected] | https://twitter.com/axeyked
The Pharmaceutical firm received the final approval for its Fluocinolone Acetonide Oil. The ear drops have been suitably developed to treat eczema of the ear. Glenmark Pharmaceuticals (Glenmark), a …
The exclusive licensing agreement is for the development as well as commercialization of a TRK modulator called PBI-100. The company aims to develop the TRK modulator for a plethora …
The partnership will offer Innovent rights to develop and commercialize products in new markets. Renowned biopharmaceutical firm, Innovent Biologics and Incyte Corp. have recently entered into a strategic collaboration …
The Australian health & beauty company has made an A$727 million offer to acquire Sigma Healthcare. The move aims to reinforce API’s position in the market in the wake …
The partnership agreement has specifically been forged to expedite the adoption of interoperability inside the healthcare industry of the UK. The partnership amalgamates communities of both the organizations through …
The Roche and Merck partnership is expected to expand the use of the biomarker panel for helping to select patients having solid tumors for immunotherapy The new diagnostic test …
The company raised $20 million through a series A funding round. Black Diamond also has another financing round in the works that would be announced at a later date. …
Olympus Corp. would be paying over $85 million as part of the plea agreement. The company to take corrective actions to prevent a repeat of the incident in the …
The collaboration would evaluate select drugs from both companies in combination with each other. In conjunction with the collaboration, Bristol-Myers would also make an equity investment in Vedanta. Bristol-Myers …
Evox Therapeutics, an Oxford-based, privately held biotechnology firm has reportedly announced that it has successfully secured funding from the Bill & Melinda Gates Foundation to help its drug development …
